University of Patras
Ανάπτυξη κλινικών δεικτών αξιόπιστης εκτίμησης κινδύνου για εμφάνιση αθηροσκληρωτικών νόσων στον άνθρωπο
Abstract
dc:descriptionThe present doctorate thesis has led to the development of simple and innovative methodologies for the isolation, characterization and fractionation of low density lipoproteins (LDLs) into their main molecular components. The ultimate aim of this thesis is to study/measure the specific oxidative modifications present on LDL components, that characterize the oxidized LDL (oxLDL) particles, which in turn are causally related to the development of atheromatous plaques and therefore to the risk of subsequent cardiovascular diseases (CVDs). The methods developed in the present thesis include: (a) A simple, relatively fast and low-cost method for the isolation of LDL particles (LDLP)from human blood serum, in order to avoid the disadvantages of the currently used ultracentrifugation and affinity chromatography methods. (b) Confirmation of the purity of the, isolated with the proposed methodology, LDL-P through SDS-PAGE electrophoresis of their protein component (apolipoprotein B100, apoB100), and determination of the size of LDL-P. The latter as well as the concentration of LDL-P in serum are estimated by means of a developed simple, clinically applicable - in comparison with existing nuclear magnetic resonance (NMR)methodologies - method while their value as risk indicators for the development of CVDs is also evaluated. (c) A method for the fractionation of LDL, for the first time, into its individual protein/lipid (apoB100, cholesterol esters, triglycerides, free cholesterol, phospholipids) and antioxidant (carotenoids, tocopherols) components. (d) Methods for the quantification, for the first time, of certain specific - representative of the initial effects of oxidative stress - oxidative modifications/markers in the molecular components of LDL (cholesteryl ester-OOH, triglyceride-OOH, free cholesterol-OOH, phospholipid-OOH, apoB100- MDA, apoB100-DiTyr), out of the many (known/unknown/under development) oxidative modifications that collectively characterize the oxidative state of oxLDL. These methods for oxLDL state evaluation differ significantly when compared to the existing non-specific and unreliable methods for assessing the oxidative status ofoxLDL. The aforementioned oxLDL markers are being studied for the first time in patients prone to atherosclerosis development as well as in patients with established atherosclerotic lesions and CVDs. Specifically, the selected patient groups include: patients with chronic kidney disease(CKD) on hemodialysis, patients with CKD on peritoneal dialysis, patients with abdominal aortic aneurysm patients and patients with carotid artery disease. Additionally, within the framework of the present thesis, a structural study of the apoB100 protein of LDL particles was carried out, as this remains a poorly studied protein with an unknown structure. Initially, a biophysical characterization of the solubilized apoB100 was performed by studying its secondary structure (by circular dichroism analysis, CD analysis), its thermal stability (by differential scanning fluorescence, nanoDSF) and the existence of aggregates in its solution (by dynamic scattering light, DLS). The biophysical characterization of apoB100 was followed by LCP (Liquid Cubic Phase) crystallization screens of the protein and measurement of the resulting crystals by X-ray diffraction. In summary, the isolation of LDL particles and their fractionation into their individual protein, lipid and antioxidant components paves the way for future studies regarding the investigation and quantification of all possible LDL oxidative modifications and thus paves the way for the full characterization of the so far unknown oxidative status of oxLDL particles. This may also lead to further studies for the identification of the oxLDL modifications that are responsible for their recognition by the macrophages and the impending transformation of the latter into foam cells, which are responsible for the formation of atherosclerotic lesions that in turn lead to the development of CVDs. Lastly, the biophysical characterization experiments and the LCP crystallization screens of apoB100, performed for the first time in the framework of this thesis, are the trigger for further apoB100 crystallization studies that will lead to the solving the so far unknown structure of apoB100 and to the elucidation its function and role in the development of atherosclerotic lesions.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papadea, Polyxeni
- Παπαδέα, Πολυξένη
Subjects
dc:subject × 16- Οξειδωτικό στρες
- Αθηροσκλήρωση
- Δομική βιοχημεία
- Κλινικοί δείκτες
- Oxidative stress
- Atherosclerosis
- Structural biochemistry
- Clinical markers
- Βιολογία
- Φυσικές Επιστήμες
- Βιοχημεία και Μοριακή βιολογία
- Βιοχημικές ερευνητικές μέθοδοι
- Biological Sciences
- Natural Sciences
- Biochemistry and Molecular Biology
- Biochemical Research Methods
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/54998